Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Endometriosis: Leuprorelin acetate is indicated for management of endometriosis, including pain relief and reduction of endometriotic lesions. Leuprorelin acetate monthly with norethindrone acetate 5 mg daily is also indicated for initial management of endometriosis and for management of recurrence of symptoms. Duration of initial treatment or retreatment should be limited to 6 months.
Uterine leiomyomata (fibroids): Leuprorelin acetate concomitantly with iron therapy is indicated for the preoperative hematologic improvement of patients with anemia caused by uterine leiomyomata. The clinician may wish to consider a one-month trial period on iron alone in as much as some of the patients will respond to iron alone. (see Table 1.) Leuprorelin acetate may be added if the response to iron alone is considered inadequate. Recommended duration of therapy with leuprorelin acetate is up to three months.
Experience with leuprorelin acetate in females has been limited to women 18 years of age and older. (See Table 1.)

Click on icon to see table/diagram/image

Endmet Indications/Uses

leuprorelin

Manufacturer:

MedEthix

Distributor:

MedEthix